日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Butyrate-preconditioned human adipose-derived stem cell-conditioned medium enhances myocardial perfusion after infarction

丁酸盐预处理的人脂肪干细胞条件培养基可增强心肌梗死后的心肌灌注

Kobuchi, Shinji; Hsu, Wan-Tseng; Matsuzawa, Misaki; Kagawa, Rina; Watanabe, Junko; Harada, Koki; Toda, Yuki; Hamada, Shohei; Tsujimoto, Masayuki; Kawashima, Hidekazu; Nishimura, Kaneyasu; Matsumoto, Kenjiro; Takata, Kazuyuki

Extracting Clinical Guideline Information Using Two Large Language Models: Evaluation Study

利用两种大型语言模型提取临床指南信息:评估研究

Hsu, Hsing-Yu; Chen, Lu-Wen; Hsu, Wan-Tseng; Hsieh, Yow-Wen; Chang, Shih-Sheng

Extracellular vesicle-enriched secretome of adipose-derived stem cells upregulates clusterin to alleviate doxorubicin-induced apoptosis in cardiomyocytes.

脂肪来源干细胞的细胞外囊泡富集分泌组上调簇蛋白,以减轻阿霉素诱导的心肌细胞凋亡

Hsu Wan-Tseng, Kobuchi Shinji, Chien Tung-Chun Russell, Chen I-Chun, Hamada Shohei, Tsujimoto Masayuki, Tsai I-Lin, Wong Yun-Sheng, Tung Kuan-Hsuan, He Ying-Zhen

Improving Medication Adherence in Heart Failure Through Pharmacist-Led Patient Education: Protocol for a Mechanism-Based Study of Information, Motivation, and Behavioral Skills

通过药师主导的患者教育提高心力衰竭患者的用药依从性:基于机制的信息、动机和行为技能研究方案

Chien, Tung-Chun Russell; Weng, Shao-En; Hsu, Wan-Tseng

The Worsening Renal Perfusion Index Predicts the Prognoses of Heart Failure Patients Treated with Sacubitril/Valsartan

肾灌注指数恶化可预测接受沙库巴曲/缬沙坦治疗的心力衰竭患者的预后

Hsu, Wan-Tseng; Cheng, Yu-Yang; Yang, Tsun-Yu; Chang, Chao-Kai; Lin, Yi-Hsuan; Lee, Chii-Ming; Huang, Tao-Min

Anemia warrants treatment to improve survival in patients with heart failure receiving sacubitril-valsartan

对于接受沙库巴曲缬沙坦治疗的心力衰竭患者,贫血需要治疗以提高生存率。

Yang, Tsun-Yu; Lee, Chii-Ming; Wang, Shih-Rong; Cheng, Yu-Yang; Weng, Shao-En; Hsu, Wan-Tseng